Abstract: Disclosed are exemplary embodiments of sediment/erosion/perimeter control devices and methods of making and using the same. In exemplary embodiments, a system comprises a convertible silt fence/scour pad and a wattle. The wattle is integrated with the convertible silt fence/scour pad such that the convertible silt fence/scour pad and the wattle are an integrated, singular, or unitary product. The convertible silt fence/scour pad is deployable in at least a first orientation and a second orientation. In the first orientation, the convertible silt fence/scour pad is generally vertical and/or generally perpendicular relative to the ground or other surface supporting the wattle, whereby the convertible silt fence/scour pad is operable primarily as a silt fence.

Abstract: Disclosed are exemplary embodiments of sediment/erosion/perimeter control devices and methods of making and using the same. In exemplary embodiments, a sediment/erosion/perimeter control device (e.g., a wattle, etc.) comprises a material configured such that the sediment/erosion/perimeter control device is reconfigurable between at least a first configuration and a second configuration. In the first configuration, the sediment/erosion/perimeter control device has a first size, shape, volume, and/or weight. In the second configuration, the sediment/erosion/perimeter control device has a second size, shape, volume, and/or weight substantially larger than the corresponding first size, shape, volume, and/or weight that the sediment/erosion/perimeter control device has in the first configuration.

Abstract: Methods and compositions are provided for lyophilization of bacteria or Listeria strains, such as Listeria monocytogenes. Provided are methods for producing a lyophilized composition comprising a bacteria or Listeria strain, formulations for lyophilization comprising a bacteria or Listeria strain, lyophilized bacteria or Listeria strains, and methods of preparing frozen bacteria or Listeria strains for lyophilization.

Abstract: Disclosed are exemplary embodiments of woven silt fences including integrally woven pockets for support posts. In exemplary embodiments, a woven silt fence fabric includes one or more integrated pockets integrally woven within the woven silt fence fabric. The one or more integrated pockets are configured for receiving one or more support posts therein. In exemplary embodiments, a woven silt fence comprises the woven silt fence fabric and one or more support posts configured to be received within corresponding ones of the one or more integrated pockets integrally woven within the woven silt fence fabric. The one or more support posts may be configured to be positioned within corresponding ones of the one or more integrated pockets and driven into the ground for supporting the woven silt fence without requiring any fasteners for attachment of the one or more support posts to the woven silt fence fabric.

Abstract: This invention relates to local administration of a bone-forming agent and at least one anti-resorptive agent to treat osteoporosis and related disorders.

Abstract: The present invention relates to trans-capsularly administering into a diseased joint a high specificity antagonist selected from the group consisting of: i) an inhibitor of a pro-inflammatory interleukin; ii) an inhibitor of TNF-? synthesis; iii) an inhibitor of membrane-bound TNF-?; iv) an inhibitor of a natural receptor of TNF-?; v) an inhibitor of NO synthase, vi) an inhibitor of PLA2 enzyme; vii) an anti-proliferative agent; viii) an anti-oxidant; ix) an apoptosis inhibitor selected from the group consisting of EPO mimetic peptides, EPO mimetibodies, IGF-I, IGF-II, and caspase inhibitors, and x) an inhibitor of MMPs; and xi) an inhibitor of p38 kinase.

Abstract: The present invention relates to administering autologous uncultured cells into a diseased intervertebral disc.

Abstract: The present invention relates to administering autologous uncultured cells into a diseased intervertebral disc.

Abstract: The present invention relates to administering autologous uncultured cells into a diseased intervertebral disc.

Abstract: This invention relates to local administration of a bone-forming agent and at least one anti-resorptive agent to treat osteoporosis and related disorders.

Abstract: The present invention relates to injecting a cycline compound into a diseased intervertebral disc.

Abstract: The present invention relates to trans-capsularly administering into a diseased joint a high specificity antagonist selected from the group consisting of: i) an inhibitor of a pro-inflammatory interleukin; ii) an inhibitor of TNF-? synthesis; iii) an inhibitor of membrane-bound TNF-?; iv) an inhibitor of a natural receptor of TNF-?; v) an inhibitor of NO synthase, vi) an inhibitor of PLA2 enzyme; vii) an anti-proliferative agent; viii) an anti-oxidant; ix) an apoptosis inhibitor selected from the group consisting of EPO mimetic peptides, EPO mimetibodies, IGF-I, IGF-II, and caspase inhibitors, and x) an inhibitor of MMPs; and xi) an inhibitor of p38 kinase.

Abstract: The present invention relates to injecting a high affinity antagonist of MMPs into a diseased intervertebral disc.

Abstract: The present invention relates to injecting a high specificity p38 kinase inhibitor into a diseased intervertebral disc.

Abstract: The present invention relates to administering autologous uncultured cells into a diseased intervertebral disc.

Abstract: This invention relates to an intervertebral motion disc having an articulation interface and a locking interface.

Abstract: This invention relates to an intervertebral motion disc having an articulation interface and a locking interface.

Abstract: This invention relates to local administration of a bone-forming agent and at least one anti-resorptive agent to treat osteoporosis and related disorders.